Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C for Iron Supplementation in IDA
NCT02631668Phase 4Completed
- Sponsor
- Huashan Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ascorbic acid in iron deficiency anemia (IDA) (3 arms), sponsored by Huashan Hospital. Primary endpoint: Hemoglobin at 2 weeks. Started Jan 2016; status: completed.
02
Drugs
ascorbic acid
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02631668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631668.